Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous ... - PR Newswire (press release) PDF Print
PR Newswire (press release)
Vascugel has demonstrated clinical proof of concept in two Phase 2 clinical trials involving patients with ESRD who require a permanent arteriovenous (AV)

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129